Beurs.nl
Uitgebreid zoeken
monitor iconMarkt Monitor
  • AEX +0,02 913,97 +0,00%
  • DE40 0,00 23.154,57 0,00%
  • US500^ -61,85 5.616,20 -1,09%
  • US30^ -282,40 41.576,80 -0,67%
  • EUR/USD +0,00 1,0944 +0,20%
  • WTI -0,71 66,53 -1,06%
  • Gold spot +33,49 3.033,82 +1,12%

Relief therapeutics Holding

9.106 Posts
Pagina: «« 1 ... 451 452 453 454 455 456 »» | Laatste | Omlaag ↓
  2. Forecast2006 28 december 2022 16:01

    • Forecast2006

      Lid sinds: 30 mrt 2006

      Laatste bezoek: 17 feb 2025

    • Aanbevelingen

      Ontvangen: 330

      Gegeven: 463

    •    Aantal posts: 2.112

    quote:

    Keeprolling schreef op 27 december 2022 18:53:

    De koers is er per saldo niets mee opgeschoten. Terug naar de beginstand vandaag.
    Komt goed, Amerika is positief op dit moment.

    Kind regards,
    Forecast
  3. forum rang 10 DeZwarteRidder 28 december 2022 16:27

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 18 mrt 2025

    • Aanbevelingen

      Ontvangen: 24631

      Gegeven: 10662

    •    Aantal posts: 102.562

    quote:

    Keeprolling schreef op 27 december 2022 18:53:

    De koers is er per saldo niets mee opgeschoten. Terug naar de beginstand vandaag.
    De koers gaat onvermijdelijk verder zakken.

    2 cent is al veel te duur.
  7. [verwijderd] 2 januari 2023 13:08

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Wat zijn hier de verwachtingen voor 2023?
    Wordt het het jaar van de ommekeer met eindelijk een product op de markt van ACER en de beursgang op Nasdaq?
  9. forum rang 10 DeZwarteRidder 2 januari 2023 13:25

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 18 mrt 2025

    • Aanbevelingen

      Ontvangen: 24631

      Gegeven: 10662

    •    Aantal posts: 102.562

    Pursuant to a Share Subscription Facility agreement (SSF),

    GEM committed to provide up to CHF 50 million to RELIEF

    THERAPEUTICS Holding SA in exchange for registered shares of

    RELIEF THERAPEUTICS Holding SA in the period from

    January 20, 2021, to January 20, 2024, at the discretion of

    RELIEF THERAPEUTICS Holding SA, subject to certain

    exceptions and limitations. No drawdowns have been made

    until December 19, 2022,resulting in a remaining balance of

    the full amount under the SSF of CHF 50 million. GEM's

    purchase position has been calculated using the closing

    price of the registered shares of RELIEF THERAPEUTICS

    Holding SA on SIX Swiss Exchange on December 19, 2022 (CHF

    0.0288) and applying the 10% discount agreed in the SSF

    (resulting in a share price of CHF 0.02592), by dividing the

    remaining balance under the SSF of CHF 50 million by such

    share price of CHF 0.02592. However, according to the

    terms of the SSF, future subscription prices under the SSF

    will correspond to 90% of the average of the closing bid

    prices on SIX Swiss Exchange during the relevant reference

    period, which corresponds to 15 trading days following

    RELIEF THERAPEUTICS Holding SA's relevant subscription

    request, subject to certain exceptions and limitations.

    Therefore, note that the actual subscription price at which

    GEM may be requested to subscribe for registered shares

    of RELIEF THERAPEUTICS Holding SA under the SSF may be lower

    or higher than the share price applied above, and

    accordingly, the number of voting rights GEM may acquire as

    a result thereof may be higher or lower than as set

    forth in this disclosure.
  12. forum rang 10 DeZwarteRidder 2 januari 2023 13:42

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 18 mrt 2025

    • Aanbevelingen

      Ontvangen: 24631

      Gegeven: 10662

    •    Aantal posts: 102.562

    quote:

    €50_is_€50 schreef op 2 januari 2023 13:34:

    Mss moeten ze aviptadil maar in China op de markt brengen, ridder! ;-p
    Dat is een heel goed idee......!!!

    Aan een zieke Chinees kun je alles verkopen wat lijkt op een geneesmiddel.........
  14. laatsteloodje 9 januari 2023 16:35

    • laatsteloodje

      Lid sinds: 08 jan 2023

      Laatste bezoek: 17 nov 2024

    • Aanbevelingen

      Ontvangen: 1

      Gegeven: 0

    •    Aantal posts: 25

    quote:

    DeZwarteRidder schreef op 2 januari 2023 13:42:

    Aan een zieke Chinees kun je alles verkopen wat lijkt op een geneesmiddel.........
    Dat is toch heel goed nieuws. Als 0,1% van de 1,4 miljard chinesen dit nutteloos middel kopen......
  16. forum rang 10 DeZwarteRidder 5 mei 2023 11:58

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 18 mrt 2025

    • Aanbevelingen

      Ontvangen: 24631

      Gegeven: 10662

    •    Aantal posts: 102.562

    Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares
    03.05.2023 / 07:00 CET/CEST

    Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares

    GENEVA (May 3, 2023) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief Therapeutics), a biopharmaceutical company committed to delivering innovative treatment options with the potential for transformative outcomes to benefit those suffering from select specialty and rare diseases, today announced the implementation timeline for the reverse split of its ordinary shares, which was approved by shareholders at the Extraordinary General Meeting held on April 28, 2023.

    May 4, 2023: Last trading day of old shares on SIX Swiss Exchange
    May 5, 2023: First trading day of new shares on SIX Swiss Exchange

    As previously communicated, shareholdings will be rounded down to the next lower whole number of new merged shares by applying the 400 to 1 exchange ratio. The resulting fractions will be compensated in cash at a fixed price corresponding to the three-day volume-weighted average price of the Relief Therapeutics share on the SIX Swiss Exchange prior to the reverse split.

    Additional information on the reverse split is provided in a Q&A list available here.

    ABOUT RELIEF THERAPEUTICS

    Relief Therapeutics is a commercial-stage biopharmaceutical company committed to advancing treatment paradigms and delivering improvements in efficacy, safety and convenience to benefit the lives of patients living with select specialty and rare diseases. Relief Therapeutics’ portfolio offers a balanced mix of marketed, revenue-generating products, our proprietary, globally patented Physiomimic™ and TEHCLO™ drug delivery platform technologies and a highly targeted clinical development pipeline consisting of risk-mitigated assets focused in three core therapeutic areas: rare metabolic disorders, rare skin diseases and rare respiratory diseases. In addition, Relief Therapeutics is commercializing several legacy products via licensing and distribution partners. Our mission to provide therapeutic relief to those suffering from rare diseases is being advanced by an international team of well-established, experienced biopharma industry leaders with extensive research, development and rare disease expertise. Relief Therapeutics is headquartered in Geneva, with additional offices in Balerna, Switzerland, Offenbach am Main, Germany and Rome. Relief Therapeutics is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbols RLFTF and RLFTY. For more information, please visit our website www.relieftherapeutics.com or follow Relief Therapeutics on LinkedIn and Twitter
  21. forum rang 10 DeZwarteRidder 1 september 2023 12:14

    • DeZwarteRidder

      Lid sinds: 29 jun 2012

      Laatste bezoek: 18 mrt 2025

    • Aanbevelingen

      Ontvangen: 24631

      Gegeven: 10662

    •    Aantal posts: 102.562

    quote:

    Ronduit schreef op 1 september 2023 12:11:

    Weer wat leven in de brouwerij. +40%, maar dat is ook niet zo gek met zo'n lage koers.
    Tjonge, jonge, zit je nog steeds met deze troep te knoeien.....????
9.106 Posts
Pagina: «« 1 ... 451 452 453 454 455 456 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beurs.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.103
AB InBev 2 5.531
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.003
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.819
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.793
Aedifica 3 925
Aegon 3.258 323.026
AFC Ajax 538 7.088
Affimed NV 2 6.303
ageas 5.844 109.900
Agfa-Gevaert 14 2.062
Ahold 3.538 74.345
Air France - KLM 1.025 35.256
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.049
Alfen 16 25.135
Allfunds Group 4 1.515
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 417
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.680
AMG 971 134.179
AMS 3 73
Amsterdam Commodities 305 6.743
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.035
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.789
Arcelor Mittal 2.034 320.916
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.349
Aroundtown SA 1 221
Arrowhead Research 5 9.750
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.578
ASML 1.766 109.678
ASR Nederland 21 4.507
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.764
Axsome Therapeutics 1 177
Azelis Group 1 66
Azerion 7 3.439